<DOC>
	<DOCNO>NCT02913521</DOCNO>
	<brief_summary>A Double-Blind , Randomized , Placebo-Controlled , Parallel Group , Three-Arm , Multi-Site Study Evaluate Therapeutic Equivalence Diclofenac Sodium Topical Gel 1 % ( Hi-Tech Pharmacal Co. , Inc. ) With Voltaren® Gel ( Diclofenac Sodium Topical Gel ) 1 % ( Novartis ) Patients With Osteoarthritis Knee</brief_summary>
	<brief_title>Bioequivalence Study With Clinical Endpoint Diclofenac Sodium Topical Gel 1 %</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>1 . Ambulatory male nonpregnant female 35 year old diagnose osteoarthritis accord American College Rheumatology Criteria ( ACR ) one knee . Target knee one high level pain . ACR Criteria include : Knee Pain least 3 follow : age ≥ 50 , stiffness last &lt; 30 min , bony tenderness , crepitus , bony enlargement , palpable warmth . 2 . Symptom onset &gt; 6 Months prior Screening target knee . 3 . If female childbearing potential , prepare abstain sexual intercourse use reliable method contraception study ( e.g. , IUD , oral , transdermal , injected , implanted hormonal contraceptive condom + spermicide ) . 4 . Periarticular knee pain due osteoarthritis ( bursitis , tendonitis etc . ) require use oral topical treatment ( e.g. , NSAIDs acetaminophen ) . 5 . Radiograph target knee within previous year Grade 1 , 2 3 disease base upon KellgrenLawrence disease severity scale . 6 . After minimum 7day wash pain medication Baseline pain movement score ≥ 50mm 0100mm Visual Analogue Scale target knee . 7 . After minimum 7day wash pain medication Baseline WOMAC Pain sub scale ≥ 9 5 question , 5 point ( 0 4 ) Likert scale target knee . 8 . Willing able use acetaminophen rescue medication . 9 . Willing able comply study requirement . 1 . Females pregnant , breast feeding , plan pregnancy . 2 . Radiograph target knee within previous year Grade 4 score KellgrenLawrence disease severity scale . 3 . History osteoarthritis contralateral knee require medication ( OTC prescription ) within 12 month screen . 4 . After minimum 7day wash pain medication Baseline pain movement score ≥ 20mm 0100mm Visual Analogue Scale contralateral knee immediately prior randomization . 5 . Known history secondary osteoarthritis ( e.g . congenital , traumatic , gouty arthritis ) knee rheumatoid arthritis . 6 . Known history chronic inflammatory disease , ( e.g. , colitis ) fibromyalgia last 5 year . Patients whose disease diagnose least 5 ( five ) year prior screen visit know disease activity ( i.e. , disease related complaint disease treatment prescribe ) since may enter study . 7 . History asthma , hypertension , myocardial infarction , thrombotic event , stroke , congestive heart failure , impaired renal function liver disease . Patients high blood pressure measure least 2 ( two ) year prior screen visit disease activity ( i.e. , record hypertension antihypertensive treatment prescribe ) least 2 ( two ) year prior screen visit may enter study . 8 . History coronary artery bypass graft within 6 month screen . 9 . Concomitant acetylsalicylic acid therapy stable low dose use cardiac prophylaxis ( max . 162 mg daily ) take least 3 month prior enrollment maintain throughout duration study . 10 . Use warfarin anticoagulant therapy within 30 day screen . 11 . Use ACE inhibitor , cyclosporine , diuretic , lithium methotrexate , within 30 day screen study . 12 . Known history gastrointestinal bleeding peptic ulcer disease . 13 . Abnormal screen clinical laboratory evaluation Investigator deem clinically significant . 14 . Known allergy aspirin NSAIDs . 15 . Skin lesion wound affected area . 16 . Significant ( require surgery ) injury major knee surgery either knee within six month prior screen . 17 . Transaminase level two time upper limit normal range screening . 18 . Any acute chronic illness opinion investigator could compromise integrity study data place Patient risk participate study . 19 . Concomitant use corticosteroid ( formulation ) use within 30 day study randomization . 20 . Receipt drug part research study within 30 day prior screen . 21 . Previous randomization study . 22 . Known allergy ( hypersensitivity ) acetaminophen .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>